MAI Capital Management - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2023$264,362
+58.5%
19,087
+70.1%
0.00%
+100.0%
Q2 2023$166,834
+5.6%
11,221
+6.5%
0.00%
-75.0%
Q1 2019$158,000
+4.6%
10,534
-11.1%
0.01%
-11.1%
Q4 2018$151,000
-27.1%
11,8530.0%0.01%
-18.2%
Q3 2018$207,000
+3.5%
11,853
-9.7%
0.01%0.0%
Q2 2018$200,000
+0.5%
13,1260.0%0.01%0.0%
Q1 2018$199,000
+19.2%
13,1260.0%0.01%
+22.2%
Q4 2017$167,00013,1260.01%
Other shareholders
Astellas Pharma Inc shareholders Q4 2017
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 483,681$7,616,0000.34%
TODD ASSET MANAGEMENT LLC 202,400$3,153,0000.07%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 202,400$3,153,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 112,575$1,772,0000.01%
Private Capital Group, LLC 1,084$17,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 43$1,0000.00%
IFP Advisors, Inc 511$8,0000.00%
MEEDER ASSET MANAGEMENT INC 23$00.00%
CAPTRUST FINANCIAL ADVISORS 4,089$64,0000.00%
View complete list of Astellas Pharma Inc shareholders